|
|||
![]() |
|||
2007-10-25 09:23:39 CEST 2007-10-25 09:23:39 CEST REGULATED INFORMATION Raisio - Company AnnouncementRAISIO TO GAIN ADDITIONAL RIGHTS TO STANOL ESTER AND BENECOL BRANDRaisio plc, Stock Exchange Release 25 October 2007 RAISIO TO GAIN ADDITIONAL RIGHTS TO STANOL ESTER AND BENECOL BRAND Raisio and its United States' partner, McNeil Nutritionals, LLC, and its European partner, Cilag GmbH International, have signed an amendment to their agreement that will return the rights to the stanol ester compound to Raisio in the United States, Great Britain, France, Ireland, and Benelux countries. In addition, Raisio will gain rights to the Benecol brand in France and the United States in categories in which McNeil and Cilag are not currently active. In return Raisio will make royalty payments and provide marketing support to McNeil and Cilag. Cilag will retain exclusive rights to the Benecol brand in Great Britain, Ireland, Belgium, and Luxembourg. McNeil and Cilag will also retain rights in the categories in which they currently hold strong positions in both France and the United States. Raisio aims to be an active player in the growing European, Asian and United States markets for cholesterol-lowering functional foods by introducing innovative product applications. Raisio's strength in different market areas is its adaptability. This means that Benecol brand products are launched in the market with local partners in applications matching the local consumption habits. RAISIO PLC Heidi Hirvonen Communications Manager tel. +358 2 443 2242 or +358 50 567 3060 Further information: Matti Rihko, CEO, tel. +358 400 830 727 Distribution: OMX Nordic Exchange, Helsinki Key media www.raisio.com |
|||
|